Metraipolis › archive › dc_60538bf3dffe

An AI-Assisted Workflow for Rapid Prioritization of FDA-Approved Drugs as HDAC3 Inhibitor Candidates for Drug Repurposing — Europe PMC PMID:42792516

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42792516
DOI
10.3390/biology15181570
License (as archived)
solo-consultazione
Archived
2026-10-06T19:41:31.009Z
SHA-256 of the archived text
653af88c80b23bb4afc3441059184858c32987d7a7f58314aed0ff891612258c
Stable URL of this page
https://metraipolis.com/documento/dc_60538bf3dffe

How to cite

An AI-Assisted Workflow for Rapid Prioritization of FDA-Approved Drugs as HDAC3 Inhibitor Candidates for Drug Repurposing — Europe PMC PMID:42792516 — Europe PMC (en), https://europepmc.org/article/MED/42792516 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_60538bf3dffe (Metraipolis archive dc_60538bf3dffe, sha256 653af88c80b23bb4afc3441059184858c32987d7a7f58314aed0ff891612258c)
BibTeX
@misc{dc60538bf3dffe,
  title = {An AI-Assisted Workflow for Rapid Prioritization of FDA-Approved Drugs as HDAC3 Inhibitor Candidates for Drug Repurposing — Europe PMC PMID:42792516},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42792516},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_60538bf3dffe; sha256 653af88c80b23bb4afc3441059184858c32987d7a7f58314aed0ff891612258c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42792516. Agents can read the archived copy with the MCP tool read_document.